EyePoint Pharmaceuticals
EYPT
#5227
Rank
โ‚ฌ1.26 B
Marketcap
15,31ย โ‚ฌ
Share price
0.45%
Change (1 day)
82.75%
Change (1 year)

EyePoint Pharmaceuticals (EYPT) - Net assets

Net assets on the balance sheet as of September 2025 : โ‚ฌ0.17 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company has โ‚ฌ0.17 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

EyePoint Pharmaceuticals - Net assets on balance sheet (from 2003 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$โ‚ฌ0.32 B34.22%
2023-12-31$โ‚ฌ0.24 B168.16%
2022-12-31$โ‚ฌ89.83 M-44.82%
2021-12-31$โ‚ฌ0.16 B980.05%
2020-12-31$โ‚ฌ15.07 M102.72%
2019-12-31$โ‚ฌ7.43 M
2018-06-30$โ‚ฌ9.98 M-14.56%
2017-06-30$โ‚ฌ11.68 M-37.84%
2016-06-30$โ‚ฌ18.8 M-10.41%
2015-06-30$โ‚ฌ20.98 M92.56%
2014-06-30$โ‚ฌ10.89 M84.2%
2013-06-30$โ‚ฌ5.91 M-45.08%
2012-06-30$โ‚ฌ10.77 M-58.28%
2011-06-30$โ‚ฌ25.82 M-2.25%
2010-06-30$โ‚ฌ26.41 M58.68%
2009-06-30$โ‚ฌ16.64 M-12.84%
2008-06-30$โ‚ฌ19.1 M-69.27%
2007-06-30$โ‚ฌ62.16 M-39.41%
2006-06-30$โ‚ฌ0.10 B102.35%
2005-06-30$โ‚ฌ50.7 M130.93%
2004-06-30$โ‚ฌ21.95 M493.44%
2003-06-30$โ‚ฌ3.69 M
2001-06-30$โ‚ฌ5.38 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
NRC Health
NRC
โ‚ฌ12.29 M-92.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
-โ‚ฌ2.48 Million-101.44% Bahamas